PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 297 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 9.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,891,000 | -37.6% | 49,580 | -18.3% | 0.16% | -22.5% |
| Q1 2022 | $4,630,000 | -9.9% | 60,660 | -49.2% | 0.20% | -8.7% |
| Q4 2018 | $5,138,000 | -53.7% | 119,440 | -47.0% | 0.22% | -31.3% |
| Q3 2018 | $11,086,000 | +0.2% | 225,545 | +56.6% | 0.32% | -3.9% |
| Q4 2015 | $11,062,000 | -3.5% | 144,060 | +11.4% | 0.33% | +12.5% |
| Q4 2014 | $11,466,000 | +87.6% | 129,325 | +48.1% | 0.30% | +69.5% |
| Q3 2014 | $6,113,000 | -27.1% | 87,339 | -4.4% | 0.17% | -24.7% |
| Q2 2014 | $8,390,000 | +37.2% | 91,339 | +4.6% | 0.23% | +32.8% |
| Q1 2014 | $6,113,000 | -16.1% | 87,339 | -31.1% | 0.17% | -17.5% |
| Q4 2013 | $7,286,000 | -7.0% | 126,738 | +56.8% | 0.21% | -4.5% |
| Q3 2013 | $7,835,000 | +109.7% | 80,836 | -37.3% | 0.22% | +78.2% |
| Q2 2013 | $3,736,000 | – | 128,835 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |